Charlotta Enerbäck

4.4k total citations · 1 hit paper
61 papers, 2.5k citations indexed

About

Charlotta Enerbäck is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Charlotta Enerbäck has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 29 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Charlotta Enerbäck's work include Psoriasis: Treatment and Pathogenesis (27 papers), S100 Proteins and Annexins (14 papers) and Dermatology and Skin Diseases (8 papers). Charlotta Enerbäck is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (27 papers), S100 Proteins and Annexins (14 papers) and Dermatology and Skin Diseases (8 papers). Charlotta Enerbäck collaborates with scholars based in Sweden, United States and Germany. Charlotta Enerbäck's co-authors include Robert Sabat, Anna Balato, Kamran Ghoreschi, Maria Yhr, Tommy Martinsson, Anna‐Karin Ekman, Annica Inerot, Fredrik Enlund, Cecilia Bivik and G Swanbeck and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Charlotta Enerbäck

60 papers receiving 2.4k citations

Hit Papers

Therapeutics targeting the IL-23 and IL-17 pathway in pso... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    2021 397 citations Kamran Ghoreschi, Anna Balato et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Enerbäck Sweden 31 1.5k 1.0k 602 443 352 61 2.5k
Nori Matsunami United States 20 922 0.6× 1.1k 1.1× 322 0.5× 380 0.9× 434 1.2× 26 2.8k
Askar M. Akimzhanov United States 16 1.4k 0.9× 669 0.7× 113 0.2× 332 0.7× 193 0.5× 25 2.2k
Rainer Spanbroek Germany 17 2.0k 1.3× 875 0.9× 93 0.2× 508 1.1× 394 1.1× 20 3.4k
Smriti K. Raychaudhuri United States 22 1.2k 0.8× 376 0.4× 488 0.8× 208 0.5× 189 0.5× 39 2.0k
Gayathri Perera United Kingdom 15 1.1k 0.7× 320 0.3× 506 0.8× 178 0.4× 396 1.1× 22 2.0k
Ezra Vadai Israel 23 1.5k 0.9× 1.6k 1.5× 129 0.2× 716 1.6× 1.2k 3.4× 44 3.5k
Masaru Honma Japan 21 514 0.3× 382 0.4× 482 0.8× 177 0.4× 181 0.5× 78 1.4k
Evelyn P. Murphy Ireland 29 864 0.6× 712 0.7× 68 0.1× 322 0.7× 98 0.3× 46 2.1k
Nella Prevete Italy 27 903 0.6× 849 0.8× 52 0.1× 477 1.1× 261 0.7× 60 2.0k
Yossi Ovadya Israel 14 665 0.4× 1.0k 1.0× 131 0.2× 193 0.4× 1.3k 3.6× 16 2.4k

Countries citing papers authored by Charlotta Enerbäck

Since Specialization
Citations

This map shows the geographic impact of Charlotta Enerbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Enerbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Enerbäck more than expected).

Fields of papers citing papers by Charlotta Enerbäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Enerbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Enerbäck. The network helps show where Charlotta Enerbäck may publish in the future.

Co-authorship network of co-authors of Charlotta Enerbäck

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Enerbäck. A scholar is included among the top collaborators of Charlotta Enerbäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Enerbäck. Charlotta Enerbäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verma, Deepti, et al.. (2023). Differential DNA Methylation of MicroRNA-Encoding Genes in Psoriatic Epidermis Highlights the Wnt Pathway. Journal of Investigative Dermatology. 143(8). 1594–1597.e14. 2 indexed citations
2.
Bivik, Cecilia, Ines Köhler, Deepti Verma, et al.. (2021). MTH1 Inhibitors for the Treatment of Psoriasis. Journal of Investigative Dermatology. 141(8). 2037–2048.e4. 15 indexed citations
3.
Ghoreschi, Kamran, Anna Balato, Charlotta Enerbäck, & Robert Sabat. (2021). Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. The Lancet. 397(10275). 754–766. 397 indexed citations breakdown →
4.
Ekman, Anna‐Karin, Cecilia Bivik, Ingemar Rundquist, & Charlotta Enerbäck. (2019). IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis. Journal of Investigative Dermatology. 139(7). 1564–1573.e8. 54 indexed citations
5.
Ekman, Anna‐Karin, Cecilia Bivik, Ingemar Rundquist, & Charlotta Enerbäck. (2019). 292 IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis. Journal of Investigative Dermatology. 139(5). S51–S51. 4 indexed citations
6.
Yu, Ning, et al.. (2018). The Act1 D10N missense variant impairs CD40 signaling in human B-cells. Genes and Immunity. 20(1). 23–31. 4 indexed citations
7.
Enerbäck, Charlotta, et al.. (2017). Involved and Uninvolved Psoriatic Keratinocytes Display a Resistance to Apoptosis that may Contribute to Epidermal Thickness. Acta Dermato Venereologica. 97(7). 788–796. 21 indexed citations
8.
Verma, Deepti, Anna‐Karin Ekman, Cecilia Bivik, & Charlotta Enerbäck. (2017). Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis. Journal of Investigative Dermatology. 138(5). 1088–1093. 47 indexed citations
9.
Ekman, Anna‐Karin, et al.. (2016). Overexpression of Psoriasin (S100A7) Contributes to Dysregulated Differentiation in Psoriasis. Acta Dermato Venereologica. 97(4). 441–448. 43 indexed citations
10.
Nikamo, Pernilla, Stanley Cheuk, Charlotta Enerbäck, et al.. (2014). Genetic Variants of the IL22 Promoter Associate to Onset of Psoriasis before Puberty and Increased IL-22 Production in T Cells. Journal of Investigative Dermatology. 134(6). 1535–1541. 36 indexed citations
11.
Ekman, Anna‐Karin, et al.. (2013). Systemically Elevated Th1-, Th2- and Th17-associated Chemokines in Psoriasis Vulgaris Before and After Ultraviolet B Treatment. Acta Dermato Venereologica. 93(5). 527–531. 30 indexed citations
12.
Kovács, Anikó, et al.. (2012). The Expression of Psoriasin (S100A7) and CD24 Is Linked and Related to the Differentiation of Mammary Epithelial Cells. PLoS ONE. 7(12). e53119–e53119. 20 indexed citations
13.
Shubbar, Emman, et al.. (2011). Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Research and Treatment. 134(1). 71–80. 64 indexed citations
14.
Shubbar, Emman, et al.. (2009). Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Melanoma Research. 19(4). 215–225. 31 indexed citations
15.
Anderson, Karen S., et al.. (2009). Detection of psoriasin/S100A7 in the sera of patients with psoriasis. British Journal of Dermatology. 160(2). 325–332. 38 indexed citations
16.
Erlandson, Anna, et al.. (2007). Novel CDKN2A Mutations Detected in Western Swedish Families with Hereditary Malignant Melanoma. Journal of Investigative Dermatology. 127(6). 1465–1467. 8 indexed citations
17.
18.
O'Brien, Kevin P., et al.. (2001). The HCR Gene on 6p21 is Unlikely to be a Psoriasis Susceptibility Gene. Journal of Investigative Dermatology. 116(5). 750–754. 37 indexed citations
19.
Enerbäck, Charlotta, Annica Inerot, Fredrik Enlund, et al.. (1999). Cytogenetic analysis of 477 psoriatics revealed an increased frequency of aberrations involving chromosome region 11q. European Journal of Human Genetics. 7(3). 339–344. 5 indexed citations
20.
Söderpalm, Bo, Gun Andersson, Charlotta Enerbäck, & J. Engel. (1997). In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with brain GABAA/ benzodiazepine receptor complexes. Neuropharmacology. 36(8). 1071–1077. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nori Matsunami Breakdown of academic impact, for papers by Askar M. Akimzhanov Breakdown of academic impact, for papers by Rainer Spanbroek Breakdown of academic impact, for papers by Smriti K. Raychaudhuri Breakdown of academic impact, for papers by Gayathri Perera Breakdown of academic impact, for papers by Ezra Vadai Breakdown of academic impact, for papers by Masaru Honma Breakdown of academic impact, for papers by Evelyn P. Murphy Breakdown of academic impact, for papers by Nella Prevete Breakdown of academic impact, for papers by Yossi Ovadya
Rankless by CCL
2026